Iain D. Dukes insider trades
Open-market stock purchases and sales by Iain D. Dukes, Chief Executive Officer at Traws Pharma, Inc, from SEC Form 4 filings since Aug 16, 2016.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +83%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 9, 2026 | TRAW Traws Pharma, Inc | Bought (not open market) | — |
| Jun 16, 2026 | IOVA Iovance Biotherapeutics, Inc | Bought (not open market) | — |
| Mar 8, 2026 | TRAW Traws Pharma, Inc | Bought (not open market) | — |
| Dec 12, 2025 | TRAW Traws Pharma, Inc | Bought (not open market) | — |
| Dec 12, 2025 | TRAW Traws Pharma, Inc | Bought (not open market) | — |
Companies traded
- TRAW Traws Pharma, Inc: other filings, last Jul 9, 2026
- IOVA Iovance Biotherapeutics, Inc: 3 buys, last Jun 16, 2026
- NONE Lomond Therapeutics Holdings, Inc: other filings, last Nov 1, 2024
- IKNA Ikena Oncology, Inc: other filings, last Jun 7, 2024
- THRX Theseus Pharmaceuticals, Inc: other filings, last Feb 14, 2024
- LBIO Lion Biotechnologies, Inc: other filings, last Jun 1, 2017